Jabodon Pt CO Aerie Pharmaceuticals Inc Transaction History

Jabodon Pt CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 10, 2019	SELL	$36.32 - $49.25 $1.77 Million - $2.4 Million	-48,820 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$33.0 - $60.04 $1.61 Million - $2.93 Million	48,820 New	48,820 $1.76 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

Stay updated on Jabodon Pt CO with notifications on news.